Nantong Jinchao Machinery Co., Ltd. , https://www.ntjinzhaomachine.com
Judging from the contents of the announcement, Libang Instrument did not clearly indicate the impact of the lawsuit on its listing, and only said that the relevant products accounted for a small proportion, "does not affect the company's ability to continue operations."
The details of the lawsuit has not been disclosed yet Libang Instrument said in its announcement last night that on April 10th it was learned from related media reports that Shenzhen Mindray Biomedical Electronics Co., Ltd. (Meinui Company) filed a lawsuit with Shenzhen Intermediate People’s Court on April 8. , Libang Instrument multi-parameter monitoring products violated Mindray's intellectual property rights, claiming a total of 25 million yuan, "according to the verdict way to the Intermediate People's Court of Shenzhen Municipal People's Court filing case, the Shenzhen Intermediate People's Court filing cabinet confirmed that the Mindray company sued the issuer (ie, Libang Instrument) The series of intellectual property infringement cases is true."
However, the announcement stated that the details of the lawsuit and the product of the design were not yet known, because Libang Instrument defended that since the relevant case had not yet been confirmed as the advisor, the court could not provide detailed case information temporarily, nor did it accept the case's written materials.
However, Libang Instrument subsequently gave an explanation based on the current report on the data related to litigation-related products in the company's revenue.
Libang Instrument Co., Ltd. said that according to Mindray, Libang's multi-parameter monitoring products "M8 patient monitor", "M9 patient monitor", "M80 patient monitor" and "M50 patient monitor" allegedly infringed Mindray. The company invented a patent, three utility model patents and trade secrets, and the above-mentioned products involved in the infringement of the case claimed sales of 11.4463 million yuan, 12.5895 million yuan, 39.9162 million yuan respectively, which accounted for 6.51 percent of the operating income for the current period. %, 5.50%, and 12.22%, gross profit amounted to RMB 5,351,100, RMB 6,733,500 and RMB 20,696,400, respectively, which accounted for 5.55%, 5.03%, and 11.02% of the total gross profit for the period, respectively, which are all small, “does not affect Libang Instrument sustainability."
However, Libang Instrument did not mention the impact of this matter on its listing. Libang Instrument stated in its announcement that its product R&D strategy is based on independent research and development. In the past three years, Ribang Instrument continuously maintained R&D investment of more than 10% of operating income. The company obtained 12 proprietary core technologies in the field of surveillance products through continuous independent R&D. "The company's related monitoring products were independently developed and did not infringe the patents of Mindray."
The institutional cold is of interest to offline subscriptions. Today is just the day of purchase of Ribang Instruments. In the previous research reports issued by a number of brokers, the financial performance of Ribang was universally recognized.
For example, Guangzhou Securities believes that Libang Instrument is a leading company in the subdivision industry. It is recommended that investors choose Libang Instruments as the first choice for online purchases today. Shenyin Wanguo also believes that Libang Instrument's gross profit margin is relatively prominent, and the online success rate will also be higher, which is the preferred choice for online subscription.
However, it is worth mentioning that, according to the release announcement announced by Libang Instrument on April 12, the institutional funds involved in the purchase of the stock market can be said to be cautious. The oversubscription of the company's offline subscription is 3.9 times. This is the listed company with the lowest subscription rate under offline sales among GEM companies issued this year.
Obviously, the recent two-day public report shows that in addition to the complaints of infringement announced yesterday by Libang Instrument, in previous media reports, it was even pointed out that Libang Instrument had commercial violations. For example, in Shaanxi, the local financial department announced that it would ban Libang Instruments from participating in local government procurement activities.
Industry insiders are concerned that the listing plan of Libang Instrument may be affected.
Shenzhen Libang Precision Instrument Co., Ltd. (Ricoh Instrument, 300206), which is going to make an online purchase today, suddenly issued an announcement confirming that the company actually suffered an infringement lawsuit.